VIROSODE

Active substance: ECHINACEA ANGUSTIFOLIA, GOLDENSEAL, LOMATIUM DISSECTUM WHOLE, PHYTOLACCA AMERICANA ROOT, ACONITUM NAPELLUS, ARSENIC TRIOXIDE, ATROPA BELLADONNA, HUMAN BREAST TUMOR CELL, HUMAN COXSACKIEVIRUS A, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, HUMAN HERPESVIRUS 3, INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) WHOLE, INFLUENZA A VIRUS A/NORTH CAROLINA/04/2016 (H3N2) WHOLE, INFLUENZA B VIRUS B/IOWA/06/2017 WHOLE, INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 WHOLE, MEASLES VIRUS, HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED, RANCID BEEF

LIQUID · ECHINACEA ANGUSTIFOLIA 8 [hp_X]/mL, GOLDENSEAL 8 [hp_X]/mL, LOMATIUM DISSECTUM WHOLE 8 [hp_X]/mL, PHYTOLACCA AMERICANA ROOT 8 [hp_X]/mL, ACONITUM NAPELLUS 30 [hp_C]/mL, ARSENIC TRIOXIDE 30 [hp_C]/mL, ATROPA BELLADONNA 30 [hp_C]/mL, HUMAN BREAST TUMOR CELL 30 [hp_C]/mL, HUMAN COXSACKIEVIRUS A 30 [hp_C]/mL, EUPATORIUM PERFOLIATUM FLOWERING TOP 30 [hp_C]/mL, GELSEMIUM SEMPERVIRENS ROOT 30 [hp_C]/mL, HUMAN HERPESVIRUS 3 30 [hp_C]/mL, INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) WHOLE 30 [hp_C]/mL, INFLUENZA A VIRUS A/NORTH CAROLINA/04/2016 (H3N2) WHOLE 30 [hp_C]/mL, INFLUENZA B VIRUS B/IOWA/06/2017 WHOLE 30 [hp_C]/mL, INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 WHOLE 30 [hp_C]/mL, MEASLES VIRUS 30 [hp_C]/mL, HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED 30 [hp_C]/mL, RANCID BEEF 30 [hp_C]/mL

United StatesActive

Marketing holder: Natural Creations, Inc

Verified 2026-10-09 · openFDA NDC

Analogues in other countries

Source: openFDA NDC
Countries with the substance registered: 2

Composition

ECHINACEA ANGUSTIFOLIA · 8 [hp_X]/mL
GOLDENSEAL · 8 [hp_X]/mL
LOMATIUM DISSECTUM WHOLE · 8 [hp_X]/mL
PHYTOLACCA AMERICANA ROOT · 8 [hp_X]/mL
ACONITUM NAPELLUS · 30 [hp_C]/mL
ARSENIC TRIOXIDE · 30 [hp_C]/mL
ATROPA BELLADONNA · 30 [hp_C]/mL
HUMAN BREAST TUMOR CELL · 30 [hp_C]/mL
HUMAN COXSACKIEVIRUS A · 30 [hp_C]/mL
EUPATORIUM PERFOLIATUM FLOWERING TOP · 30 [hp_C]/mL
GELSEMIUM SEMPERVIRENS ROOT · 30 [hp_C]/mL
HUMAN HERPESVIRUS 3 · 30 [hp_C]/mL
INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) WHOLE · 30 [hp_C]/mL
INFLUENZA A VIRUS A/NORTH CAROLINA/04/2016 (H3N2) WHOLE · 30 [hp_C]/mL
INFLUENZA B VIRUS B/IOWA/06/2017 WHOLE · 30 [hp_C]/mL
INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 WHOLE · 30 [hp_C]/mL
MEASLES VIRUS · 30 [hp_C]/mL
HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED · 30 [hp_C]/mL
RANCID BEEF · 30 [hp_C]/mL

Products containing arsenic trioxide in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

Country	Products
EU 4	Arsenic trioxide Accord arsenic trioxide EMEA/H/C/005175 Accord Healthcare S.L.U. Arsenic trioxide medac arsenic trioxide EMEA/H/C/005218 medac Gesellschaft für klinische Spezialpräparate mbH Trisenox arsenic trioxide EMEA/H/C/000388 Teva B.V. Arsenic trioxide Mylan arsenic trioxide EMEA/H/C/005235 Mylan Ireland Limited

Registration

Registration number: 43406-0593
Registration status: Active
Dispensing: Over the counter
Route: ORAL

Sources

product · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.5 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.6 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.7 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.8 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.9 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.10 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.11 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.12 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.13 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.14 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.15 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.16 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.17 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source
ingredients.18 · openFDA NDC · 43406-0593 · Verified 2026-10-09 · open in source